388 related articles for article (PubMed ID: 26077647)
61. STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance.
Thiagarajan PS; Zheng Q; Bhagrath M; Mulkearns-Hubert EE; Myers MG; Lathia JD; Reizes O
Endocr Relat Cancer; 2017 Aug; 24(8):415-426. PubMed ID: 28729467
[TBL] [Abstract][Full Text] [Related]
62. Phosphorylation and stabilization of topoisomerase IIα protein by p38γ mitogen-activated protein kinase sensitize breast cancer cells to its poisons.
Qi X; Hou S; Lepp A; Li R; Basir Z; Lou Z; Chen G
J Biol Chem; 2011 Oct; 286(41):35883-35890. PubMed ID: 21878638
[TBL] [Abstract][Full Text] [Related]
63. Microenvironmental Regulation of Long Noncoding RNA LINC01133 Promotes Cancer Stem Cell-Like Phenotypic Traits in Triple-Negative Breast Cancers.
Tu Z; Schmöllerl J; Cuiffo BG; Karnoub AE
Stem Cells; 2019 Oct; 37(10):1281-1292. PubMed ID: 31283068
[TBL] [Abstract][Full Text] [Related]
64. Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity.
Bamodu OA; Huang WC; Tzeng DT; Wu A; Wang LS; Yeh CT; Chao TY
Cancer Lett; 2015 Aug; 364(2):125-34. PubMed ID: 25976769
[TBL] [Abstract][Full Text] [Related]
65. MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer.
Kim YJ; Choi JS; Seo J; Song JY; Lee SE; Kwon MJ; Kwon MJ; Kundu J; Jung K; Oh E; Shin YK; Choi YL
Int J Cancer; 2014 May; 134(10):2424-36. PubMed ID: 24615768
[TBL] [Abstract][Full Text] [Related]
66. Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.
Hou ZJ; Luo X; Zhang W; Peng F; Cui B; Wu SJ; Zheng FM; Xu J; Xu LZ; Long ZJ; Wang XT; Li GH; Wan XY; Yang YL; Liu Q
Oncotarget; 2015 Mar; 6(8):6326-40. PubMed ID: 25811972
[TBL] [Abstract][Full Text] [Related]
67. The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer.
Wan X; Zheng X; Pang X; Zhang Z; Jing T; Xu W; Zhang Q
Int J Pharm; 2015 Apr; 484(1-2):16-28. PubMed ID: 25700543
[TBL] [Abstract][Full Text] [Related]
68. G-quadruplex structural dynamics at MAPK12 promoter dictates transcriptional switch to determine stemness in breast cancer.
Sengupta P; Dutta A; Suseela YV; Roychowdhury T; Banerjee N; Dutta A; Halder S; Jana K; Mukherjee G; Chattopadhyay S; Govindaraju T; Chatterjee S
Cell Mol Life Sci; 2024 Jan; 81(1):33. PubMed ID: 38214819
[TBL] [Abstract][Full Text] [Related]
69. p38γ mitogen-activated protein kinase (MAPK) confers breast cancer hormone sensitivity by switching estrogen receptor (ER) signaling from classical to nonclassical pathway via stimulating ER phosphorylation and c-Jun transcription.
Qi X; Zhi H; Lepp A; Wang P; Huang J; Basir Z; Chitambar CR; Myers CR; Chen G
J Biol Chem; 2012 Apr; 287(18):14681-91. PubMed ID: 22399296
[TBL] [Abstract][Full Text] [Related]
70. Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancer.
Hsu YH; Yao J; Chan LC; Wu TJ; Hsu JL; Fang YF; Wei Y; Wu Y; Huang WC; Liu CL; Chang YC; Wang MY; Li CW; Shen J; Chen MK; Sahin AA; Sood A; Mills GB; Yu D; Hortobagyi GN; Hung MC
Cancer Res; 2014 Sep; 74(17):4822-35. PubMed ID: 24970481
[TBL] [Abstract][Full Text] [Related]
71. Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6.
Hsiao YC; Yeh MH; Chen YJ; Liu JF; Tang CH; Huang WC
Oncotarget; 2015 Nov; 6(35):37965-78. PubMed ID: 26513016
[TBL] [Abstract][Full Text] [Related]
72. p38γ MAPK Is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis.
Wang F; Qi XM; Wertz R; Mortensen M; Hagen C; Evans J; Sheinin Y; James M; Liu P; Tsai S; Thomas J; Mackinnon A; Dwinell M; Myers CR; Bartrons Bach R; Fu L; Chen G
Cancer Res; 2020 Aug; 80(16):3251-3264. PubMed ID: 32580961
[TBL] [Abstract][Full Text] [Related]
73. Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions.
Damelin M; Bankovich A; Park A; Aguilar J; Anderson W; Santaguida M; Aujay M; Fong S; Khandke K; Pulito V; Ernstoff E; Escarpe P; Bernstein J; Pysz M; Zhong W; Upeslacis E; Lucas J; Lucas J; Nichols T; Loving K; Foord O; Hampl J; Stull R; Barletta F; Falahatpisheh H; Sapra P; Gerber HP; Dylla SJ
Clin Cancer Res; 2015 Sep; 21(18):4165-73. PubMed ID: 26015513
[TBL] [Abstract][Full Text] [Related]
74. Depletion of SENP1 suppresses the proliferation and invasion of triple-negative breast cancer cells.
Wang Z; Jin J; Zhang J; Wang L; Cao J
Oncol Rep; 2016 Oct; 36(4):2071-8. PubMed ID: 27573572
[TBL] [Abstract][Full Text] [Related]
75. Inhibition of LIPG phospholipase activity suppresses tumor formation of human basal-like triple-negative breast cancer.
Lo PK; Yao Y; Zhou Q
Sci Rep; 2020 Jun; 10(1):8911. PubMed ID: 32488004
[TBL] [Abstract][Full Text] [Related]
76. TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development.
Czerwińska P; Shah PK; Tomczak K; Klimczak M; Mazurek S; Sozańska B; Biecek P; Korski K; Filas V; Mackiewicz A; Andersen JN; Wiznerowicz M
Oncotarget; 2017 Jan; 8(1):863-882. PubMed ID: 27845900
[TBL] [Abstract][Full Text] [Related]
77. Disulfiram suppresses cancer stem-like properties and STAT3 signaling in triple-negative breast cancer cells.
Kim YJ; Kim JY; Lee N; Oh E; Sung D; Cho TM; Seo JH
Biochem Biophys Res Commun; 2017 May; 486(4):1069-1076. PubMed ID: 28373070
[TBL] [Abstract][Full Text] [Related]
78. Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells.
Bierie B; Pierce SE; Kroeger C; Stover DG; Pattabiraman DR; Thiru P; Liu Donaher J; Reinhardt F; Chaffer CL; Keckesova Z; Weinberg RA
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):E2337-E2346. PubMed ID: 28270621
[TBL] [Abstract][Full Text] [Related]
79. Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2.
Pandiella A; Morís F; Ocaña A; Núñez LE; Montero JC
Oncotarget; 2015 Oct; 6(32):32856-67. PubMed ID: 26439989
[TBL] [Abstract][Full Text] [Related]
80. Pro-oncogenic role of alternative p38 mitogen-activated protein kinases p38γ and p38δ, linking inflammation and cancer in colitis-associated colon cancer.
Del Reino P; Alsina-Beauchamp D; Escós A; Cerezo-Guisado MI; Risco A; Aparicio N; Zur R; Fernandez-Estévez M; Collantes E; Montans J; Cuenda A
Cancer Res; 2014 Nov; 74(21):6150-60. PubMed ID: 25217523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]